Table 3 Antibiotic resistance of Esherichia coli according to extended-spectrum beta-lactamases phenotype in fecal samples from Libyan children
ESBL + ve | ESBL-ve | P-Value* | Total | |
|---|---|---|---|---|
(N = 18) | (N = ll6) | (N = l34) | ||
Ampicillin | 18 (100)** | 87 (75) | 0.02 | 105 (78.4) |
Ampicillin/Sulbactam | 17 (94.4) | 59 (50.9) | 0.0005 | 76 (56.7) |
Amoxicillin/Clavulanic | 17 (94.4) | 69 (59.5) | 0.3 | 86 (64.2) |
Imipenem | 0 (0.0) | 0 (0.0) | N/A | 0 (0.0) |
Cephalothin | 18 (100) | 79 (68.1) | 0.003/ | 97 (72.4) |
Cefotaxime | 18 (100) | 9 (7.8) | <0.0001 | .27 (20.2) |
Ceftriaxone | 18 (100) | 8 (6.9) | <0.0001 | 26 (19.4) |
Ceftazidime | 18 (100) | 9 (7.8) | <0.0001 | 27 (20.2) |
Chloramphenicol | 17 (94.4) | 30 (25.9) | <0.0001 | 47 (35.1) |
Nalidixic acid | 5 (27.8) | 8 (6.9) | 0.03 | 13 (9.7) |
Ciprofloxacin | 5 (27.8) | 2 (1.7) | 0.0009 | 7 (5.2) |
Streptomycin | 16 (88.9) | 69 (59.5) | 0.02 | 85 (63.4) |
Trimethoprim/sulfamethoxazole | 14 (77.8) | 69 (59.5) | 0.2 | .83 (61.9) |
Tetracycline | 16 (88.9) | 54 (46.6) | 0.001 | 70 (52.2) |